Reports of Past Research Periods
Overall, almost 2.5 million euros were used for glioblastoma research til today. Three projects are supported in each funding period. Regular reports to the Scientific Advisory Board and the Executive Board were made by the research teams.
26.09.2013 – 31.01.2015
Prof. Dr. Glass (Munich) with the Project: Mesenchymal stem cells modulate glioma progression
(Only available in German)
Prof. Dr. Lamszus (Hamburg) with the Project: Importance of brain tumor metabolism for the interaction between tumor cells and brain tissue
(Only available in German)
Prof. Dr. Herold-Mende (Heidelberg) with the Project: Immunological changes and adaptation of the tumor environment in the course of glioblastoma progression
(Only available in German)
01.01.2016 – 31.12.2017
Prof. Dr. Glass (Munich) with the Projecta: Tumor-associated mesenchymal stem cells – target of new treatment strategies for glioblastomas
(Only available in German)
Prof. Dr. Lamszus (Hamburg) with the Project: Tumor metabolism – interaction between tumor cells and brain tissue
(Only available in German)
Prof. Dr. Herold-Mende (Heidelberg) with the Project: Immunological changes and adaptation of the tumor environment in the course of glioblastoma progression
(Only available in German)
01.01.2018 – 31.12.2019
Prof. Dr. Glass (Munich) with the Project: New pericytes in brain tumor blood-vessels originate from a previously unrecognized pericyte progenitor
Prof. Dr. Lamszus (Hamburg) with the Project: Identification of immunosuppressive mechanisms in glioblastomas and their evaluation as therapeutic targets
Prof. Dr. Herold-Mende (Heidelberg) with the Project: Therapeutic application of T cell targets and TAM inhibitors
(Only available in German)
01.01.2020 – 31.12.2021
Prof. Dr. Glass (Munich) with the Project: TAMEP shape neoplastic-angiogenesis in Glioblastoma
Prof. Dr. Lamszus (Hamburg) with the Project: Immunomodulatory effects of anti-angiogenic treatment and radiotherapy in glioblastoma models
Dr. Burger (Frankfurt) with the Project: Targeted local combination therapy with checkpoint inhibitors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors
01.01.2022 – 31.12.2023
Prof. Dr. Glass (Munich) with the Project: Cell biological and pathological traits of TAMEP indicate new therapeutic targets for glioblastoma
(Only available in German)
Prof. Dr. Lamszus (Hamburg) with the Project: Relevance of extracellular vesicles in tumor-immune cell interactions
(Only available in German)
Dr. Burger (Frankfurt) with the Project: Targeted local combination therapy with checkpoint inhibtors and CAR-NK cells in glioblastoma using DARPin-linked AAV vectors
(Only available in German)
